Hongwei Lu

7PUBLICATIONS
9CO-AUTHORS
Medical infection agents (incl. prions)Epidemiological methodsHaematological tumoursTissue engineeringCell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 01, 2026
Macrophage FTO deficiency accelerates atherosclerosis via PACS2-mediated activation of the PPARĪ³ lipid signaling pathway.

Jie Ouyang, Zishun Zhan, Haijiao Long

|Feb 15, 2026
Quercetin Alleviates Endothelial Dysfunction in Atherosclerosis by Inhibiting Ferroptosis Through PACS2/HMOX-1 Pathway.

Hai-Jiao Long, Quan-Jun Liu, Shi-Ying Qin

|Jun 11, 2025
S1PR2 Mediates Smooth Muscle Cell Proliferation and Endothelial Cell Permeability via Akt/mTOR and RhoA/ROCK1 in Atherosclerosis.

Jie Ouyang, Haijiao Long, Shuhua Chen

|May 13, 2022
Research progress of endothelial-mesenchymal transition in diabetic kidney disease.

Ying Chen, Hang Zou, Hongwei Lu

|May 13, 2022
Glucolipotoxicity induces endothelial cell dysfunction by activating autophagy and inhibiting autophagic flow.

Yulan Liu, Hong Xiang, Wenfang Xiong

|Feb 17, 2021
Role of sphingosine-1-phosphate receptors in vascular injury of inflammatory bowel disease.

Xuewen Wang, Shuhua Chen, Hong Xiang

Pageof 2

Frequent Collaborators

2 joint publications

Shuhua Chen

1 joint publications

Hai-Jiao Long

1 joint publications

Quan-Jun Liu

1 joint publications

Shi-Ying Qin